Polyclonal Antibody to Breast Carcinoma Amplified Sequence 3 (BCAS3) is a premium-quality life science research product supplied by Torvigen for laboratory and scientific applications.
RPF221Hu01-Recombinant Breast Carcinoma Amplified Sequence 3 (BCAS3)
Recommended Usage
Western blotting: 0.5-2μg/mL< br/> Immunohistochemistry: 5-20μg/mL< br/> Immunocytochemistry: 5-20μg/mL< br/> Optimal working dilutions must be determined by end user.
